Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 341

1.

Grass tablet sublingual immunotherapy downregulates the TH2 cytokine response followed by regulatory T-cell generation.

Suárez-Fueyo A, Ramos T, Galán A, Jimeno L, Wurtzen PA, Marin A, de Frutos C, Blanco C, Carrera AC, Barber D, Varona R.

J Allergy Clin Immunol. 2014 Jan;133(1):130-8.e1-2. doi: 10.1016/j.jaci.2013.09.043. Epub 2013 Nov 28.

PMID:
24290282
2.

Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production.

Cosmi L, Santarlasci V, Angeli R, Liotta F, Maggi L, Frosali F, Rossi O, Falagiani P, Riva G, Romagnani S, Annunziato F, Maggi E.

Clin Exp Allergy. 2006 Mar;36(3):261-72.

PMID:
16499636
3.

Lack of detectable alterations in immune responses during sublingual immunotherapy in children with seasonal allergic rhinoconjunctivitis to grass pollen.

Rolinck-Werninghaus C, Kopp M, Liebke C, Lange J, Wahn U, Niggemann B.

Int Arch Allergy Immunol. 2005 Feb;136(2):134-41. Epub 2005 Jan 12.

PMID:
15650310
4.

Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity.

Nouri-Aria KT, Wachholz PA, Francis JN, Jacobson MR, Walker SM, Wilcock LK, Staple SQ, Aalberse RC, Till SJ, Durham SR.

J Immunol. 2004 Mar 1;172(5):3252-9.

5.

Sublingual grass pollen immunotherapy is associated with increases in sublingual Foxp3-expressing cells and elevated allergen-specific immunoglobulin G4, immunoglobulin A and serum inhibitory activity for immunoglobulin E-facilitated allergen binding to B cells.

Scadding GW, Shamji MH, Jacobson MR, Lee DI, Wilson D, Lima MT, Pitkin L, Pilette C, Nouri-Aria K, Durham SR.

Clin Exp Allergy. 2010 Apr;40(4):598-606. doi: 10.1111/j.1365-2222.2010.03462.x. Epub 2010 Feb 22.

PMID:
20184605
6.

Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies.

Möbs C, Ipsen H, Mayer L, Slotosch C, Petersen A, Würtzen PA, Hertl M, Pfützner W.

J Allergy Clin Immunol. 2012 Nov;130(5):1108-1116.e6. doi: 10.1016/j.jaci.2012.07.056. Epub 2012 Sep 27.

PMID:
23021882
7.

Human leukocyte antigen-G and regulatory T cells during specific immunotherapy for pollen allergy.

Sørensen AE, Johnsen CR, Dalgaard LT, Würtzen PA, Kristensen B, Larsen MH, Ullum H, Søes-Petersen U, Hviid TV.

Int Arch Allergy Immunol. 2013;162(3):237-52. doi: 10.1159/000353281. Epub 2013 Sep 6.

PMID:
24022071
8.

Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.

Reich K, Gessner C, Kroker A, Schwab JA, Pohl W, Villesen H, Wüstenberg E, Emminger W.

Clin Ther. 2011 Jul;33(7):828-40. doi: 10.1016/j.clinthera.2011.06.006. Epub 2011 Jul 7.

PMID:
21741092
10.

Pretreatment IgE sensitization patterns determine the molecular profile of the IgG4 response during updosing of subcutaneous immunotherapy with timothy grass pollen extract.

Schmid JM, Würtzen PA, Dahl R, Hoffmann HJ.

J Allergy Clin Immunol. 2016 Feb;137(2):562-70. doi: 10.1016/j.jaci.2015.05.023. Epub 2015 Jun 30.

PMID:
26141262
11.

Allergen-specific CD4+ T cell responses in peripheral blood do not predict the early onset of clinical efficacy during grass pollen sublingual immunotherapy.

Bonvalet M, Moussu H, Wambre E, Ricarte C, Horiot S, Rimaniol AC, Kwok WW, Horak F, de Beaumont O, Baron-Bodo V, Moingeon P.

Clin Exp Allergy. 2012 Dec;42(12):1745-55. doi: 10.1111/cea.12015.

PMID:
23181790
12.

Immunotherapy with a Phleum pratense allergen extract induces an immune response to a grass-mix allergen extract.

Martínez-Cócera C, Sastre J, Cimarra M, Quirce S, Fernández-Rivas M, Enríquez-Matas A, Rodríguez-Alvarez M, Martín S.

J Investig Allergol Clin Immunol. 2010;20(1):13-9.

13.

Intradermal grass pollen immunotherapy increases TH2 and IgE responses and worsens respiratory allergic symptoms.

Slovick A, Douiri A, Muir R, Guerra A, Tsioulos K, Hay E, Lam EPS, Kelly J, Peacock JL, Ying S, Shamji MH, Cousins DJ, Durham SR, Till SJ.

J Allergy Clin Immunol. 2017 Jun;139(6):1830-1839.e13. doi: 10.1016/j.jaci.2016.09.024. Epub 2016 Oct 20.

14.

Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl p 1, a major grass pollen allergen.

Ebner C, Siemann U, Bohle B, Willheim M, Wiedermann U, Schenk S, Klotz F, Ebner H, Kraft D, Scheiner O.

Clin Exp Allergy. 1997 Sep;27(9):1007-15.

PMID:
9678832
15.

Effect of sublingual immunotherapy with grass monomeric allergoid on allergen-specific T-cell proliferation and interleukin 10 production.

Burastero SE, Mistrello G, Falagiani P, Paolucci C, Breda D, Roncarolo D, Zanotta S, Monasterolo G, Rossi RE.

Ann Allergy Asthma Immunol. 2008 Apr;100(4):343-50. doi: 10.1016/S1081-1206(10)60597-2.

PMID:
18450120
16.

Immunological comparison of allergen immunotherapy tablet treatment and subcutaneous immunotherapy against grass allergy.

Aasbjerg K, Backer V, Lund G, Holm J, Nielsen NC, Holse M, Wagtmann VR, Würtzen PA.

Clin Exp Allergy. 2014 Mar;44(3):417-28.

PMID:
24734285
17.

Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation.

Möbs C, Slotosch C, Löffler H, Jakob T, Hertl M, Pfützner W.

J Immunol. 2010 Feb 15;184(4):2194-203. doi: 10.4049/jimmunol.0901379. Epub 2010 Jan 4.

18.

Epigenetic modifications and improved regulatory T-cell function in subjects undergoing dual sublingual immunotherapy.

Swamy RS, Reshamwala N, Hunter T, Vissamsetti S, Santos CB, Baroody FM, Hwang PH, Hoyte EG, Garcia MA, Nadeau KC.

J Allergy Clin Immunol. 2012 Jul;130(1):215-24.e7. doi: 10.1016/j.jaci.2012.04.021. Epub 2012 Jun 5. Erratum in: J Allergy Clin Immunol. 2012 Nov;130(5):1224.

19.

Supplemental Content

Support Center